281 related articles for article (PubMed ID: 27620880)
1. Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats.
Possomato-Vieira JS; Gonçalves-Rizzi VH; Graça TU; Nascimento RA; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1325-1332. PubMed ID: 27620880
[TBL] [Abstract][Full Text] [Related]
2. Sodium nitrite attenuates hypertension-in-pregnancy and blunts increases in soluble fms-like tyrosine kinase-1 and in vascular endothelial growth factor.
Gonçalves-Rizzi VH; Possomato-Vieira JS; Sales Graça TU; Nascimento RA; Dias-Junior CA
Nitric Oxide; 2016 Jul; 57():71-78. PubMed ID: 27181106
[TBL] [Abstract][Full Text] [Related]
3. Increases in placental nitric oxide, but not nitric oxide-mediated relaxation, underlie the improvement in placental efficiency and antihypertensive effects of hydrogen sulphide donor in hypertensive pregnancy.
Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1118-1127. PubMed ID: 29927503
[TBL] [Abstract][Full Text] [Related]
4. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
[TBL] [Abstract][Full Text] [Related]
5. Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.
Chimini JS; Possomato-Vieira JS; da Silva MLS; Dias-Junior CA
Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):385-393. PubMed ID: 30318719
[TBL] [Abstract][Full Text] [Related]
6. Cardiac myeloperoxidase activity is elevated in hypertensive pregnant rats.
Zhu ML; Zhao JP; Cui N; Gonçalves-Rizzi VH; Possomato-Vieira JS; Nascimento RA; Dias-Junior CA
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):904-909. PubMed ID: 29270751
[TBL] [Abstract][Full Text] [Related]
7. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.
Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R505-21. PubMed ID: 27280428
[TBL] [Abstract][Full Text] [Related]
8. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
[TBL] [Abstract][Full Text] [Related]
10. Both maternal and placental toll-like receptor activation are necessary for the full development of proteinuric hypertension in mice.
Chatterjee P; Chiasson VL; Kopriva SE; Bounds KR; Newell-Rogers MK; Mitchell BM
Pregnancy Hypertens; 2018 Jul; 13():154-160. PubMed ID: 30177045
[TBL] [Abstract][Full Text] [Related]
11. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA
Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241
[TBL] [Abstract][Full Text] [Related]
12. Melatonin attenuates hypertension and oxidative stress in a rat model of L-NAME-induced gestational hypertension.
Zuo J; Jiang Z
Vasc Med; 2020 Aug; 25(4):295-301. PubMed ID: 32469270
[TBL] [Abstract][Full Text] [Related]
13. Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.
Li W; Cui N; Mazzuca MQ; Mata KM; Khalil RA
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H491-H507. PubMed ID: 28626073
[TBL] [Abstract][Full Text] [Related]
14. Hypertension, augmented activity of matrix metalloproteinases-2 and -9 and angiogenic imbalance in hypertensive pregnancy are attenuated by doxycycline.
Nascimento RA; Possomato-Vieira JS; Gonçalves-Rizzi VH; Bonacio GF; Rizzi E; Dias-Junior CA
Eur J Pharmacol; 2018 Dec; 840():60-69. PubMed ID: 30336141
[TBL] [Abstract][Full Text] [Related]
15. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.
Li W; Mata KM; Mazzuca MQ; Khalil RA
Biochem Pharmacol; 2014 Jun; 89(3):370-85. PubMed ID: 24704473
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy hypertension-associated endothelial dysfunction is attenuated by isoflurane anesthesia: Evidence of protective effect related to increases in nitric oxide.
Rodrigues SD; da Silva MLS; Martins LZ; Gomes SEB; Mariani NAP; Silva EJR; Kushima H; Mattos BR; Rizzi E; Dias-Junior CA
Life Sci; 2023 Oct; 331():122039. PubMed ID: 37648198
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy.
Mazzuca MQ; Li W; Reslan OM; Yu P; Mata KM; Khalil RA
Hypertension; 2014 Sep; 64(3):632-43. PubMed ID: 24914193
[TBL] [Abstract][Full Text] [Related]
19. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1.
Edwards DL; Arora CP; Bui DT; Castro LC
Am J Obstet Gynecol; 1996 Aug; 175(2):484-8. PubMed ID: 8765273
[TBL] [Abstract][Full Text] [Related]
20. Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.
Lin C; He H; Cui N; Ren Z; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H165-H180. PubMed ID: 31834839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
